Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3296 of 6351
-
New study aims to unlock cancer secrets in american indians
Knowledge-focused Recruiting nowThis clinical trial studies engagement strategies for recruiting American Indians (AI) of Southwestern Tribal Nations for cancer genome sequencing. American Indians in the Southwest have higher rates of some types of cancer, such as cancers that arise in the liver, kidney, breast…
Sponsor: New Mexico Cancer Research Alliance • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Virtual genome center aims to close genetic care gap for newborns
Knowledge-focused OngoingThis study will provide rigorous evaluation of implementing a virtual genome center into community clinical settings without highly specialized resources, thereby offering generalizable insights as to how best to implement genomic medicine at scale and for other age groups. This …
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Can a simple ultrasound predict immunotherapy success?
Diagnosis PausedPrimary objective is to assess whether changes in quantitative tumor perfusion parameters after 3 weeks of treatment, as measured by CEUS, can predict initial objective response to therapy, defined by current standard-of-care Secondary objectives are to evaluate if there is an o…
Sponsor: Stanford University • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Brain injury epilepsy study tests At-Home program to boost memory and ease caregiver burden
Symptom relief OngoingThe purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-PTE, to improve the quality of life and cognitive function in Service Members, Veterans and civilians with post traumatic epilepsy (PTE). This study will also assess the ability of the HO…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New hope for breast cancer survivors: trial tests vaginal treatments for hormone therapy side effects
Symptom relief CompletedIn this prospective active-controlled randomized trial the investigators will assess for the first time ever the different local treatments of vulvovaginal atrophy in breast cancer patients on endocrine therapy. These patients are currently inadequately treated based on ignorance…
Phase 4 • Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can we predict who benefits from a heart device? new study aims to find out
Knowledge-focused OngoingCardiac resynchronization therapy with a defibrillator (CRT-D) in heart failure (HF) patients without left bundle branch block (non-LBBB) has been less beneficial to improve outcomes despite being a guideline indicated therapy, posing a significant treatment challenge. However, n…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Nanoparticle inhaler could tame lung transplant rejection
Disease control CompletedPatients subjected to lung transplantation develop acute rejection or chronic rejection with an incidence of 45% after the first year. The major clinical phenotype of chronic rejection is bronchiolitis obliterans syndrome (BOS), which cause an establishment of chronic lung inflam…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Immune cell therapy takes on stubborn stomach bug in transplant patients
Disease control Recruiting nowThis is a Phase I dose-escalation study to evaluate the safety of norovirus -specific T-cell (NST) therapy for chronic norovirus infection in participants following hematopoietic stem cell transplantation (HSCT) or who are immunocompromised due to PID and have not undergone HSCT,…
Phase 1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New tech program aims to ease breastfeeding pain and keep moms going
Symptom relief CompletedEvery year, 1 million women cease breastfeeding (BF) before 6 months, the minimum time required for optimal maternal and infant health, development, and well-being. The highest rate of BF cessation occurs within 3 weeks after birth, with 30% of women ceasing BF due to acute breas…
Sponsor: University of Connecticut • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Vitamin a derivative paired with Low-Dose radiation shows promise for rare skin cancer
Disease control Recruiting nowThe researchers are doing this study to test the safety of combining bexarotene with TSEB radiotherapy in people who have a common form of CTCL called mycosis fungoides (MF). Bexarotene is a form of vitamin A that activates proteins called retinoid X receptors, which may stop th…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can a transplant drug stop HHT nosebleeds? small study tests sirolimus
Disease control CompletedThis pilot study is to determine the safety and efficacy of oral sirolimus (blood trough level 6-10ng/ml) in patients with HHT that are experiencing moderate or severe epistaxis. The effect of oral sirolimus on epistaxis will be compared to baseline using the Patient-Reported Out…
Phase 2 • Sponsor: Unity Health Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Sound waves smash artery calcium in new leg treatment trial
Disease control CompletedProspective, multi-center, single-arm feasibility study to assess the safety and performance of the Shockwave Medical Mini S Peripheral IVL System for the treatment of heavily calcified, stenotic peripheral arteries.
Sponsor: Shockwave Medical, Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Stool swap: could gut germs drive eating disorders?
Knowledge-focused Recruiting nowThe intestinal microbiota plays an essential role in digestion and, through the gut-brain axis, in the regulation of weight gain and eating behavior. The balaEating disorders (EDs) are serious pathologies affecting adolescence and young adults, likely to become chronic, with long…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis is a first-in-human, Phase I/II, open-label, multi-centre, dose escalation and expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary anti-tumour activity of LM-108 as a single agent or in combination with an anti-PD-1 mAb in subjects with so…
Phase 1/2 • Sponsor: LaNova Australia Pty Limited • Aim: Disease control
Last updated Jun 26, 2026 15:31 UTC
-
New drug SKB315 targets hard-to-treat tumors in early trial
Disease control Recruiting nowThis is a multicenter, open-label, multiple-dose dose finding and expansion study to evaluate the safety, tolerability, pharmacokinetic(PK) profile, and anti-tumor efficacy of SKB315 for injection in patients with advanced solid tumors.
Phase 1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New pill could boost testosterone in men with kidney disease
Disease control Recruiting nowThis study in being conducted in men who have low testosterone and chronic kidney disease. The investigators will evaluate the effects of an oral testosterone preparation, JATENZO, on testosterone levels and hemoglobin (red blood cells).
Phase 2 • Sponsor: St. Louis University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Gut health may boost bone density: probiotic study shows promise
Disease control CompletedOsteoporosis is a systemic condition characterized by low bone mass and altered bone tissue microarchitecture, with the resulting greater bone fragility leading to fractures. Osteoporosis develops as a result of genetic and environmental factors, with the patient's lifestyle play…
Sponsor: Nordic Biotic Sp. z o.o. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Blood concentrate may boost healing of jaw bone damage from common drugs
Disease control CompletedMedication-Related Osteonecrosis of the Jaw (MRONJ) is a severe and increasingly prevalent clinical condition, defined as the presence of exposed mandibular or maxillary bone in the oral cavity persisting for at least eight weeks. The rising incidence of osteonecrosis of the jaw …
Sponsor: Poznan University of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Magnetic pulses to the brain may ease autism social struggles
Symptom relief CompletedAutism spectrum disorder (ASD) encompasses a range of limitations in reciprocal social and communicative milestones, as well as restrictive and/or repetitive patterns of behavior which lead to significant functional challenges impacting individuals throughout their lifespan. Ther…
Sponsor: Christiana Care Health Services • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Daily pill could keep migraines at bay
Disease control CompletedThe purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic migraine.
Phase 4 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 26, 2026 12:46 UTC